Remarkably, our clinical study established an active role for FZD10, delivered in small extracellular vesicles, as a potential biomarker for the early diagnosis of CRC and gastric cancer and for monitoring the treatment response [19]. The gene discussed is FZD10; the disease is gastric cancer.